

We help biotechs navigate emerging clinical access pathways.
Montana SB535 for Biotech & Healthcare - Billings Meetup
A small, casual meetup for biotech and healthcare professionals. Feel free to forward the invitation to peers.
*Light snacks will be provided. Drinks at own cost.
In May 2025, Sen. Kenneth Bogner passed SB535 which is "the most important regulatory innovation in drug approval in my lifetime" according to GMU Professor Alex Tabarrok ("Marginal Revolution").
It took until July 25, 2026, for DPHHS to adopt a set of comprehensive rules with further regulatory innovation adding onto SB535: experimental treatment review boards (ETRB). ETRBs are a competitive oversight mechanism for early access to novel treatments.
Infinita has promptly formed the first "Montana ETRB" with esteemed scientists and physicians such as Matt Kaeberlein, Felipe Sierra, Jamie Justice, Jessica Flanigan and James Burke, which is now operational (see here).
What does this mean for Montana biotech and healthcare?
We're here to discuss the coming opportunities and challenges with industry and policy professionals shaping the future of Montana.
Agenda:
5:30 - 6:00pm Casual Walk-In & Networking
6:00 - 6:15pm Rep. Curtis Schomer Talk
6:15 - 6:30pm Niklas Anzinger Talk & Q&A
6:30 - 8:00pm Open Networking
We help biotechs navigate emerging clinical access pathways.